Public healthcare initiatives have long centered on the US Generic Pharmaceuticals Market as a primary tool for curbing rising medical costs. By facilitating a competitive marketplace, federal and private health plans encourage the use of generics, which helps keep premiums and patient co-pays manageable. This focus on affordability is especially crucial for vulnerable populations who depend on...